MEDAC INTERNATIONAL

Oncology

5-FU medac (5-fluorouracil)

Adrimedac®/Doxorubin (doxorubicin)

Cisplatin medac (cisplatin)

Dacarbazine medac (dacarbazine) ●

Etomedac®/Eposin (etoposide )

Lomustine medac (lomustine)●

Methotrexat medac (methotrexate)

Mitomycin medac (mitomycin)

Navirel® (vinorelbine)

Oxaliplatin medac

Rescuvolin® (folinic acid, calcium folinate)

Sodiofolin® (folinic acid, sodium folinate)

Treosulfan medac (treosulfan)

Haematology

● Asparaginase medac (asparaginase)

Hydroxyurea medac/ hydroxycarbamide medac (hydroxycarbamide)

Oncaspar® (peg-asparaginase)

Urology

● BCG-medac (Bacillus Calmette-Guerin plus instillation system )

mito-medac® ( mitomycin plus instillation system )

 

MEDAC INTERNATIONAL

Autoimmune

Metoject® ( methotrexate )

Metotab® ( methotrexate )

Sulfasalazin medac ( sulfasalazine )

 

 

 

 

SEARCH

 
NEWS

  O Two medical appointed Dr. Jamal Al Kousi as a Marketing Manager.
 
  O Two medical appointed Mr. Faris Sandid as a Financial Manager
 
  In 24/May/2008 O Two medical found an agreement with INTAS Biopharmaceutical ltd, to import, market and distribute NEUPEG ( PEGFILGRASTIM ) in Syria.